出版社：AHRC Research Centre for Studies in Intellectual Property and Technology Law
摘要：It is widely thought that stem cell research has great medical promise.1 Many healthcare service centres and clinics around the world have, however, begun to use stem cells as therapies before such promise has been medically and scientifically validated. Such centres and clinics are labelled as ‘rogue,’2 ‘maverick,’3 or ‘trading on hope and desperation,’4 because they offer unproven stem cell-based therapies to people who are desperate5 or who have a debilitating disease and have given up on conventional medicine.6
